Bartosz Bieszczad, Damian Garbicz, Marta Świtalska, Marta K. Dudek, Dawid Warszycki, Joanna Wietrzyk, . . . Adam Mieczkowski. (2021). Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues. MDPI AG.
Chicago Style (17th ed.) CitationBartosz Bieszczad, Damian Garbicz, Marta Świtalska, Marta K. Dudek, Dawid Warszycki, Joanna Wietrzyk, Elżbieta Grzesiuk, and Adam Mieczkowski. Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity Against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues. MDPI AG, 2021.
MLA (9th ed.) CitationBartosz Bieszczad, et al. Improved HDAC Inhibition, Stronger Cytotoxic Effect and Higher Selectivity Against Leukemias and Lymphomas of Novel, Tricyclic Vorinostat Analogues. MDPI AG, 2021.